A day after approving the first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism from 23andMe, the US Food and Drug Administration (FDA) on ...
As a way to better the development of novel diagnostics to detect and diagnose genetic diseases, the US Food and Drug Administration (FDA) on Tuesday for the first time formally recognized a public ...